Citius extends CEO/EVP warrants to April 5, 2025; exercise would yield $2.3M

Citius Pharmaceuticals, Inc.

Board approved one-year extension for 1,294,498 Investor Warrants held by CEO Leonard Mazur and EVP Myron Holubiak, exercise price $1.42 each.
Also extended 240,130 Placement Agent Warrants held by H.C. Wainwright representatives, exercise price $1.9313 per share.
Warrants were originally issued in April 2019 and previously extended to April 2024; no other warrants from that offering remain.
Full exercise of all extended warrants would generate about $2.3 million in cash proceeds for the company.
All other terms and conditions of the warrants remain unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.